ArticleBiotechnology letters2018

Subcutaneous administration CpG-ODNs acts as a potent adjuvant for an HIV-1-tat-based vaccine candidate to elicit cellular immunity in BALB/c mice.

Zeinab Panahi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.